Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
RAD Regimen Increases Bone Formation and Reduces Bone Resorption and Angiogenesis in Patients with Newly Diagnosed Myeloma: Results of a Phase 2 Study — Evangelos Terpos (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
RAD Regimen Increases Bone Formation and Reduces Bone Resorption and Angiogenesis in Patients with Newly Diagnosed Myeloma: Results of a Phase 2 Study
Shared by
Meletios A Dimopoulos
RAD Regimen Increases Bone Formation and Reduces Bone Resorption and Angiogenesis in Patients with Newly Diagnosed Myeloma: Results of a Phase 2 Study
Article
2017
en
Authors
+9 more
ET
Evangelos Terpos
EK
Eirini Katodritou
AS
Argiris Symeonidis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2009
High Serum Sclerostin Correlates with Advanced Stage, Increased Bone Resorption, Reduced Osteoblast Function, and Poor Survival in Newly-Diagnosed Patients with Multiple Myeloma.
Evangelos Terpos
,
Dimitrios Christoulas
,
Eirini Katodritou
,
Cornelia Bratengeier
,
Brigitte Lindner
,
Silvia Harmelin
,
Gerhard Hawa
,
Georgios Boutsikas
,
Magdalini Migkou
,
Maria Gavriatopoulou
,
Eurydiki Michalis
,
Anastasia Pouli
,
Efstathios Kastritis
,
Konstantinos Zervas
,
Meletios A Dimopoulos
Article
2024
Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Part 1 results of a phase I/II study
Evangelos Terpos
,
Maria Gavriatopoulou
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Despina Fotiou
,
Magdalini Migkou
,
Foteini Theodorakakou
,
Vasiliki Spiliopoulou
,
Ioannis V. Kostopoulos
,
Rodanthi‐Eleni Syrigou
,
Evangelos Eleutherakis‐Papaiakovou
,
Stavros Gkolfinopoulos
,
Ourania Tsitsilonis
,
Efstathios Kastritis
,
Meletios A Dimopoulos
Article
2019
Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma
Evangelos Terpos
,
Eirini Katodritou
,
Argiris Symeonidis
,
Flora Zagouri
,
Antonis Gerofotis
,
Georgia Christopoulou
,
Maria Gavriatopoulou
,
Dimitrios Christoulas
,
Ioannis Ntanasis‐Stathopoulos
,
Alexandra Kourakli
,
Pavlina Konstantinidou
,
Efstathios Kastritis
,
Meletios A Dimopoulos
Article
2013
PFS2 In Elderly Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The MM-015 Study
Meletios A Dimopoulos
,
Maria Teresa Petrucci
,
Robin Foà
,
John Catalano
,
Martin Kropff
,
Zhinuan Yu
,
Lara Grote
,
Christian Jacques
,
Antonio Palumbo
Article
2023
P884: BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE AND DEXAMETHASONE IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: UPDATED RESULTS FROM THE PHASE 1/2 BELARD STUDY
Evangelos Terpos
,
Maria Gavriatopoulou
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Despina Fotiou
,
Magdalini Migkou
,
Foteini Theodorakakou
,
Vasiliki Spiliopoulou
,
Rodanthi Syrigou
,
Evangelos Eleutherakis‐Papaiakovou
,
Stavros Gkolfinopoulos
,
Kyriaki Manousou
,
Efstathios Kastritis
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.